Related Experiment Video

Updated: May 29, 2026

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

A concise review of hepatitis C in heart and lung transplantation

Edward Yc Kim1, Hin Hin Ko, Eric M Yoshida

  • 1Division of Gastroenterology, Gordon and Leslie Diamond Health Care Centre, Vancouver, Britist Columbia.

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|September 14, 2011
PubMed

Insights

Hepatitis C (HCV) infection poses challenges for heart and lung transplant patients. More research is needed to find safe, effective treatments that avoid graft rejection in these vulnerable transplant recipients.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Infectious Diseases

Background:

  • Hepatitis C (HCV) infection is common in solid organ transplant candidates and recipients.
  • Outcomes of HCV infection in cardiac and lung transplant recipients are not well-defined.
  • Effective antiviral treatments for HCV in these patients are lacking, complicating management.

Purpose of the Study:

  • To review the current understanding of Hepatitis C (HCV) infection in cardiac and lung transplant recipients.
  • To highlight the challenges in managing HCV in this population.
  • To identify the need for further research and clinical trials.

Main Methods:

  • Literature review on Hepatitis C (HCV) infection in solid organ transplant recipients.
  • Analysis of existing data on treatment outcomes and risks.
  • Identification of knowledge gaps and areas for future research.

Main Results:

  • Pre-transplant interferon therapy for HCV may improve outcomes.
  • Post-transplant interferon therapy carries a risk of graft rejection in cardiac and pulmonary transplants.
  • Optimal management strategies for HCV in transplant recipients are currently individualized due to limited evidence.

Conclusions:

  • Hepatitis C (HCV) infection management in heart and lung transplant recipients is challenging due to lack of safe and effective treatments.
  • Further multicentre, randomized controlled trials are essential to establish optimal HCV treatment protocols.
  • Preventing graft loss from rejection is critical, given the scarcity of suitable organs for re-transplantation.

More Related Videos

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...